- Home
- CDXS vs NXDT Comparison
CDXS vs NXDT Comparison
Compare CDXS & NXDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- NXDT
- Stock Information
- Founded
- CDXS 2002
- NXDT 2012
- Country
- CDXS United States
- NXDT United States
- Employees
- CDXS N/A
- NXDT N/A
- Industry
- CDXS Major Chemicals
- NXDT Investment Managers
- Sector
- CDXS Industrials
- NXDT Finance
- Exchange
- CDXS Nasdaq
- NXDT Nasdaq
- Market Cap
- CDXS 230.3M
- NXDT 227.2M
- IPO Year
- CDXS 2010
- NXDT N/A
- Fundamental
- Price
- CDXS $2.81
- NXDT $3.77
- Analyst Decision
- CDXS Buy
- NXDT
- Analyst Count
- CDXS 2
- NXDT 0
- Target Price
- CDXS $11.00
- NXDT N/A
- AVG Volume (30 Days)
- CDXS 1.1M
- NXDT 133.6K
- Earning Date
- CDXS 05-01-2025
- NXDT 01-01-0001
- Dividend Yield
- CDXS N/A
- NXDT 9.66%
- EPS Growth
- CDXS N/A
- NXDT N/A
- EPS
- CDXS N/A
- NXDT 0.99
- Revenue
- CDXS $59,345,000.00
- NXDT N/A
- Revenue This Year
- CDXS $14.56
- NXDT N/A
- Revenue Next Year
- CDXS $21.41
- NXDT N/A
- P/E Ratio
- CDXS N/A
- NXDT $6.41
- Revenue Growth
- CDXS N/A
- NXDT N/A
- 52 Week Low
- CDXS $2.43
- NXDT $5.89
- 52 Week High
- CDXS $6.08
- NXDT $13.07
- Technical
- Relative Strength Index (RSI)
- CDXS 42.35
- NXDT 30.48
- Support Level
- CDXS $2.43
- NXDT $3.46
- Resistance Level
- CDXS $3.04
- NXDT $4.37
- Average True Range (ATR)
- CDXS 0.22
- NXDT 0.27
- MACD
- CDXS 0.08
- NXDT 0.00
- Stochastic Oscillator
- CDXS 51.35
- NXDT 28.50
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About NXDT NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. Revenue sources include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates primarily through its operating partnership and wholly owned subsidiaries.